Continuous Versus Intermittent cARdiac Electrical moNitorinG

Description

The purpose of this study is to validate the continuous patch monitoring system to evaluate cardiac arrhythmias in patients receiving drugs that can cause cardiac complications and compare the continuous patch system with standard electrocardiograms (ECGs).

Conditions

Torsades de Pointe Caused by Drug, Long QT Syndrome

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to validate the continuous patch monitoring system to evaluate cardiac arrhythmias in patients receiving drugs that can cause cardiac complications and compare the continuous patch system with standard electrocardiograms (ECGs).

Continuous Versus Intermittent cARdiac Electrical moNitorinG

Continuous Versus Intermittent cARdiac Electrical moNitorinG

Condition
Torsades de Pointe Caused by Drug
Intervention / Treatment

-

Contacts and Locations

Saint Louis

Washington University School of Medicine, Saint Louis, Missouri, United States, 63110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of acute promyelocytic leukemia (APL) and being initiated on standard of care arsenic trioxide OR Diagnosis of solid tumor and being initiated on standard of care capecitabine (alone or as part of combination treatment) OR Diagnosis of solid tumor and being initiated on standard of care ribociclib (alone or as part of combination treatment)
  • * At least 18 years of age.
  • * No allergy to adhesive patches.
  • * Able to understand and willing to sign an IRB-approved written informed consent document.
  • * Younger than 18 years of age
  • * Allergy to adhesive patches

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Washington University School of Medicine,

Joshua D Mitchell, M.D., FACC, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

2025-12-31